InvestWiserQlife Holding AB
QLIFE · Nasdaq Stockholm · Healthcare
1.60SEK
+8.3%last day
Price as of 2 October 2026
Performance
1 month
−11.1%
1 year
−42.4%
3 years, per year
−68.4%
5 years, per year
−82.7%
Largest fall, 3 years
−100.0%
Below the peak now
−100.0%
Volatility, 1 year
95.4%
Return with dividends reinvested.
Key figures
P/E
negative earnings
P/B
12.2
Dividend yield
0.0%
Return on equity
−271.6%
Net margin
−145.9%
Market value
3 m USD
Quality, value and trend
Where Qlife Holding stands against every Nordic stock today. 100 is best.
23
Profitability and a sound balance sheet over time. Better than 23% of Nordic stocks.
1
The price measured against earnings, assets and cash flow. Better than 1% of Nordic stocks.
9
The price development over the past year. Better than 9% of Nordic stocks.
1
Quality, value and trend together. Better than 1% of Nordic stocks.
About Qlife Holding
Qlife Holding AB is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 2 employees.
Qlife Holding AB (publ), a med-tech company, manufactures and sells in-vitro diagnostic analyzers and reagents in Sweden. The company offers Egoo.Health Platform, a product platform that enables advanced biomarker testing, consisting of a small device, disposable capsules, and the supplementing software. Qlife Holding AB (publ) was incorporated in 2019 and is based in Gothenburg, Sweden.
See the full analysis in InvestWiser.
The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.
See the full analysis